Novartis Gene Therapy Meets Primary Endpoint in SMA Study

OLMA Stock  USD 5.66  0.38  7.20%   
About 59% of Olema Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Olema Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Olema Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Olema Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
NVS phase III study on experimental gene therapy candidate Intrathecal onasemnogene abeparvovec meets its primary goal.

Read at zacks.com
zacks News
  

Olema Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Olema Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Olema Pharmaceuticals Fundamental Analysis

We analyze Olema Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olema Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olema Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Olema Pharmaceuticals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Olema Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Olema Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Olema Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Olema Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Olema Pharmaceuticals Related Equities

DSGNDesign Therapeutics   6.75   
0%
100.0%
PHVSPharvaris   5.21   
0%
77.0%
LRMRLarimar Therapeutics   2.77   
0%
41.0%
CNTACentessa Pharmaceuticals   1.95   
0%
28.0%
ANTXAN2 Therapeutics   1.60   
0%
23.0%
CGEMCullinan Oncology   1.18   
0%
17.0%
NVCTNuvectis Pharma   0.55   
0%
8.0%
ERASErasca   0.54   
8.0%
0%
FENCFennec Pharmaceuticals   1.60   
23.0%
0%
GLUEMonte Rosa   1.74   
25.0%
0%
MLYSMineralys Therapeutics,   2.74   
40.0%
0%
SANASana Biotechnology   2.77   
41.0%
0%
IRONDisc Medicine   2.84   
42.0%
0%
OBIOOrchestra BioMed   2.94   
43.0%
0%
MOLNMolecular Partners   4.30   
63.0%
0%
PEPGPepGen   4.96   
73.0%
0%
ZNTLZentalis Pharmaceuticals   6.28   
93.0%
0%

Complementary Tools for Olema Stock analysis

When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio